Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3172 |  SRZN Surrozen, Inc. - Common Stock | 27.97 USD | +11.26% | -6.05% | +40.41% | +100.93% | 328.75 M USD | ||
| 3211 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | +12.32% | +18.50% | +24.74% | 315.78 M USD | ||
| 3216 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 9.22 USD | +4.77% | +6.59% | -38.16% | -37.28% | 315.02 M USD | ||
| 3231 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.88 USD | +1.31% | +3.47% | -22.71% | +179.14% | 309.64 M USD | ||
| 3244 |  BNTC Benitec Biopharma Inc. - Common Stock | 8.75 USD | -2.67% | -9.89% | -28.92% | -47.32% | 305.22 M USD | ||
| 3247 |  CTNM Contineum Therapeutics, Inc. - Common stock | 13.18 USD | +3.53% | +0.23% | -11.96% | -13.69% | 304.45 M USD | ||
| 3264 |  EYPT EyePoint, Inc. - Common Stock | 3.46 USD | +4.22% | +4.53% | -19.91% | -71.17% | 298.29 M USD | ||
| 3292 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.63 USD | +3.54% | -0.75% | -27.35% | -29.11% | 288.71 M USD | ||
| 3300 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | +2.18% | +1.63% | -1.83% | -61.26% | 286.11 M USD | ||
| 3309 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.96 USD | -2.36% | -2.55% | -12.98% | -12.83% | 283.63 M USD | ||
| 3321 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 2.70 USD | -1.82% | -13.18% | -29.32% | -40.40% | 280.48 M USD | ||
| 3327 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 2.79 USD | -0.71% | -2.45% | -22.50% | -6.06% | 276.62 M USD | ||
| 3333 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.42 USD | -0.58% | -13.85% | -48.96% | -72.51% | 274.20 M USD | ||
| 3334 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 4.53 USD | -0.66% | -6.60% | -12.88% | -18.08% | 273.90 M USD | ||
| 3350 |  QSI Quantum-Si Incorporated - Class A Common Stock | 1.22 USD | -4.69% | -11.59% | +62.67% | -32.22% | 267.04 M USD | ||
| 3353 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.91 USD | -1.55% | -3.54% | -19.41% | +15.06% | 266.51 M USD | ||
| 3357 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.46 USD | +14.06% | -11.52% | -28.08% | +143.33% | 264.37 M USD | ||
| 3360 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 3.21 USD | -3.02% | -12.30% | -27.05% | -61.09% | 263.37 M USD | ||
| 3362 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 2.89 USD | +0.35% | -7.37% | -16.95% | +13.78% | 262.95 M USD | ||
| 3372 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.03 USD | +8.42% | +7.29% | +0.98% | -40.12% | 260.49 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |